Document text
Principal Investigator: Sarah L Schlichte
Organization: UNIVERSITY OF NEBRASKA MEDICAL CENTER
Fiscal Year: 2021
Award: $19,119
Funding agency: National Heart Lung and Blood Institute
PROJECT SUMMARY/ABSTRACT
The objective of this project is to identify the mechanisms by which the antioxidant MnTnBuOE-2-PyP5+ (BuOE)
and its nanoformulation, nanoBuOE, decrease blood pressure. BuOE, a manganese porphyrin currently in
clinical trials as a radioprotector in cancer patients, has properties similar to that of mammalian superoxide
dismutase; that is, it scavenges superoxide (O2•-). The pathogenesis of hypertension, a major risk factor for
several cardiovascular disorders such as heart failure and stroke, has been linked to elevated O2•-, as this
reactive oxygen species (ROS) is known to activate the sympathetic nervous system and induce vasoconstriction,
both of which drive hypertension. Preliminary studies reveal that native BuOE rapidly and acutely decreases
blood pressure in mice to severe hypotensive levels, and that this hypotensive response is accompanied by a
significant reduction in sympathetic output. The dramatic drop in blood pressure induced by BuOE has also been
observed in cancer patients enrolled in the BuOE clinical trials. Interestingly, additional preliminary data suggest
that nanoBuOE, which is formulated to slowly release the drug, does not acutely impact blood pressure in mice.
This project is designed to test the hypotheses that: 1) native BuOE immediately and acutely decreases blood
pressure by scavenging O2•- in brain nuclei known to regulate sympathetic nerve activity; and 2) the slow-
releasing nanoBuOE accumulates in the vasculature over time to decrease O2•- and increase nitric oxide (NO•)
resulting in vasodilation and a gradual/chronic decrease in blood pressure. Changes in blood pressure,
sympathetic nerve activity, and vascular tone will be measured in hypertensive rats treated with native BuOE,
nanoBuOE, or vehicle. Further, the mechanisms by which native BuOE and nanoBuOE decrease blood pressure
will be investigated by manipulating levels of NO•, a known sympathoinhibitory molecule in the brain and
vasodilator in the vasculature. Completion of these studies will provide mechanistic insight into a potentially new
anti-hypertensive therapy for the improved treatment of hypertension. Additionally, this fellowship will support
other critical aspects of the applicant’s predoctoral training including the mastering of multiple physiological
methods and approaches, presentation of results at national conferences, publication of data, and professional
development. Together with the applicant, the Sponsor and Co-Sponsor developed a training plan specifically
tailored to the applicant and will provide a mentoring environment in which the applicant can flourish. As such,
the research project and training plan will provide the applicant with the necessary training needed to become a
critically-thinking, independent academic scientist.
Terms: <Abscission><Active Oxygen><Acute><Address><American><AngII><Angiotensin II><Anti-Hypertensive Agents><Anti-Hypertensive Drugs><Anti-Hypertensives><Antihypertensive Agents><Antihypertensive Drugs><Antihypertensives><Antioxidants><Apoplexy><BNOS><BP reduction><Bioavailability><Biologic Availability><Biological Availability><Blood><Blood - brain barrier anatomy><Blood Pressure><Blood Reticuloendothelial System><Blood Vessels><Blood-Brain Barrier><Brain><Brain Nervous System><Brain Vascular Accident><Cancer Patient><Cardiovascular><Cardiovascular Body System><Cardiovascular Diseases><Cardiovascular Organ System><Cardiovascular system><Cell Nucleus><Cerebral Stroke><Cerebrovascular Apoplexy><Cerebrovascular Stroke><Chronic><Clinical Trials><Common Rat Strains><Complex thinking><Conscious><Consciousness><Cristobalite><Critical Thinking><Data><Delayed-Action Preparations><Development><Drops><Drugs><Educational process of instructing><Encapsulated><Encephalon><Endogenous Nitrate Vasodilator><Endothelium><Endothelium-Derived Nitric Oxide><Enrollment><Ensure><Environment><Erythrocuprein><Evaluative Thinking><Excision><Extirpation><Fellowship><Goals><Heart Vascular><Heart failure><Hemato-Encephalic Barrier><Hemocuprein><Hypertension><Hypotensive Agent><Hypotensive Drugs><Hypotensives><Injections><Kidney><Kidney Urinary System><Link><Lipid Bilayers><Manganese><Measures><Mediating><Medication><Mentors><Methods><Mice><Mice Mammals><Mn element><Monitor><Mononitrogen Monoxide><Murine><Mus><Myography><NC-NOS><NNOS><NOS 1 protein><NOS type I><NOS1 protein><Nerve><Neural Constitutive Nitric Oxide Synthase><Nitric Oxide><Nitric Oxide Synthase Type I><Nitrogen Monoxide><Nitrogen Protoxide><Nucleus><Operative Procedures><Operative Surgical Procedures><Oral><Output><Oxygen Radicals><Pathogenesis><Pharmaceutic Preparations><Pharmaceutical Preparations><Physiologic><Physiologic Availability><Physiological><Porphyrins><Pro-Oxidants><Procedures><Property><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Rat><Rats Mammals><Rattus><Reactive Oxygen Species><Removal><Research><Research Grants><Research Project Grants><Research Projects><Research Training><Resistance><Risk Factors><Rodent><Rodentia><Rodents Mammals><Sand><Scientific Publication><Scientist><Silica><Silicon Dioxide><Source><Stroke><Superoxide Anion><Superoxide Dismutase><Superoxide Radical><Superoxides><Surgical><Surgical Interventions><Surgical Procedure><Surgical Removal><Sympathetic Nervous System><Teaching><Testing><Time><Training><Tridymite><Vascular Hypertensive Disease><Vascular Hypertensive Disorder><Vasodilatation><Vasodilating Agent><Vasodilation><Vasodilator Agents><Vasodilator Drugs><Vasodilators><Vasorelaxation><anti-oxidant><blood pressure reduction><bloodbrain barrier><brain attack><brain nitric oxide synthase><cardiac failure><cardiovascular disease risk><cardiovascular disorder><cardiovascular disorder risk><career><cerebral vascular accident><cerebrovascular accident><circulatory system><conference><convention><cytocuprein><design><designing><developmental><drug/agent><endothelial cell derived relaxing factor><enroll><experience><experiment><experimental research><experimental study><high blood pressure><hyperpiesia><hyperpiesis><hypertension treatment><hypertensive disease><improved><in vivo><insight><lipid bilayer membrane><lower BP><lower blood pressure><lowers blood pressure><member><nNOS enzyme><nano formulation><nano particle><nano-sized particle><nanoformulation><nanoparticle><nanosized particle><neuronal NOS><neuronal form of nitric oxide synthase><neuronal nitric oxide synthase><nitric oxide synthase 1><pre-doc><pre-doctoral><predoc><predoctoral><pressure><prevent><preventing><reduce BP><reduce blood pressure><reduction in BP><reduction in blood pressure><renal><resection><resistant><response><side effect><skills><slow release drug><success><summit><surgery><symposia><symposium><time release medication><vascular><vascular bed><vascular constriction><vasoconstriction>